United States · Bill · S
S. 2252 (116th)
Empowering States to Address Drug Costs Act
Introduced
24 July 2019
Last action
—
Status
Read twice and referred to the Committee on Finance.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Empowering States to Address Drug Costs Act This bill expands the purposes for which states may use certain drug pricing information that is disclosed to them by manufacturers through the Medicaid Drug Rebate Program. Specifically, the bill allows states to use such information in furtherance of prescription drug affordability boards or state multi-payer purchasing pools.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 24 July 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 24 July 2019
Introduced in Senate
summary · EN · 24 July 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2252
- Open data entity: https://api.congress.gov/v3/bill/116/s/2252